Sascha Berger
Partner @ TVM Capital Life Science
Munich, Germany
Sascha Berger is a Series A investor at TVM Capital Life Science in Munich focused on Health Care and Wellness. Sascha Berger joined the TVM Capital Life Science team, Munich, in September 2016. Sascha has a strong investment background with almost ten years of professional transaction and strategy experience. He has a track-record of concluding 20 M&A transactions, five of those he led as responsible project manager in his previous role as SeniorM&A Manager in a PE backed global corporation. He was a core team member in a successful EUR 2.5bn revenue cross-border merger and successfully coordinated global merger clearance procedures (USA, China, EU, Korea).
- Total investments:
- 3
- Last investment:
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries Sascha Berger invests in
Stages Sascha Berger invests in
Countries Sascha Berger invests in
Investment Focus
Industry
- Health Care 2 (67%)
- Wellness 1 (33%)
- Hospitality 1 (33%)
- Medical Device 1 (33%)
- Nursing and Residential Care 1 (33%)
Stage
- Series A 1 (33%)
- Funding Round 1 (33%)
- Venture - Series Unknown 1 (33%)
Country
- Germany 1 (33%)
- United States 1 (33%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Egg Medical
|
Egg Medical is a medical device company that offers EGGNEST, a passive protection designed to drastically reduce scatter radiation exposure for the entire cath lab team without disruption to workflow. It is an in integrated work platform built on a carbon fiber sled base designed to drastically reduce scatter radiation exposure without disruptingworkflow. | $14.3M / Mar 01, 2025 | |
Myo
|
Myo is a communication platform for the care market.they are proud to have designed a product with Myo that brings together people in care.their team is always looking for new talents who would like to work on a product for better care. | $8.6M / Series A / Jan 31, 2024 | |
|
Egg Medical
|
Egg Medical is a medical device company that offers EGGNEST, a passive protection designed to drastically reduce scatter radiation exposure for the entire cath lab team without disruption to workflow. It is an in integrated work platform built on a carbon fiber sled base designed to drastically reduce scatter radiation exposure without disruptingworkflow. | $13M / Venture - Series Unknown / Feb 26, 2022 |
Co-Investors
About TVM Capital Life Science
TVM Capital Life Science is a dedicated life science venture capital firm, with offices in Montreal, Canada and Munich, Germany. Since inception, TVM Capital Life Science has invested in entrepreneurial venture backed companies. Over several fund generations, their investment strategy has included a multi-stage investment approach spanningdiscovery to market ready companies as well as profitable companies searching for growth capital. Their investment focus has always been broad and includes investments in therapeutics, technology platforms, medtech and diagnostics. They invest in Canada, the U.S., Germany and Western Europe with their dedicated team of investment professionals based in Montreal and Munich.
TVM Capital Life Science Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Catello Somma
Associate
|
|||
Hubert Birner
Managing Partner
|
|||
Luc Marengere
Managing Partner
|
|||
Marc Riviere
General Partner
|
|||
|
Sascha Berger
Partner
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Sascha Berger invest in?
Sascha Berger invests primarily in Health Care, Wellness and Hospitality startups, most often at Series A and Funding Round stage. Most of the 3 investments tracked by Shizune back companies in Germany. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Sascha Berger last invest?
The most recent investment recorded for Sascha Berger closed in Mar 2025. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
